Long-Term Follow-up of Enhanced Holter-Electrocardiography Monitoring in Acute Ischemic Stroke.
Atrial fibrillation
Electrocardiographic monitoring
Randomized controlled trial
Stroke
Journal
Journal of stroke
ISSN: 2287-6391
Titre abrégé: J Stroke
Pays: Korea (South)
ID NLM: 101602023
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
01
04
2021
accepted:
23
09
2021
pubmed:
17
12
2021
medline:
17
12
2021
entrez:
16
12
2021
Statut:
ppublish
Résumé
Prolonged electrocardiography (ECG)-monitoring in stroke patients improves the detection of paroxysmal atrial fibrillation (pAF). However, most randomized studies only had short follow-up. We aimed to provide 3-year follow-up data for AF detection and stroke recurrence risk. We randomized 402 patients aged ≥60 years with acute ischemic strokes without AF to either enhanced and prolonged monitoring (EPM; 3×10-day Holter-ECG-monitoring) or standard-of-care (≥24 hours ECG-monitoring). The endpoint of the current analysis was AF within 36 months analyzed by intention to treat. Long-term follow-up was performed for 36 months. Two hundred and seventy-four patients (80%) participated in the extended follow-up (median duration of follow-up was 36 months [interquartile range, 12 to 36]). During the first 6 months, more AF was documented in the EPM arm compared to the control arm (13.5% vs. 5.1%; 95% confidence interval, 2.9% to 14.4%; P=0.004). During months 6 to 36, AF was less detected in the EPM intervention arm than in the control arm (2.0% vs. 7.3%; 95% confidence interval, 0.7% to 9.9%; P=0.028). Overall, the detection rate of AF within 36 months was numerically higher within the EPM group (15.0% vs. 11.1%, P=0.30). Numerically less patients in the EPM arm had recurrent ischemic strokes (5.5% vs. 9.1%, P=0.18), transient ischemic attacks (3.0% vs. 4.5%, P=0.44) or died (4.5% vs. 6.6%, P=0.37). Enhanced and prolonged ECG monitoring increased AF detection during the first six months, but there was significantly more clinical AF during months 6 to 36 observed in the usual-care arm. This suggests that EPM leads to an earlier detection of clinically relevant AF.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Prolonged electrocardiography (ECG)-monitoring in stroke patients improves the detection of paroxysmal atrial fibrillation (pAF). However, most randomized studies only had short follow-up. We aimed to provide 3-year follow-up data for AF detection and stroke recurrence risk.
METHODS
METHODS
We randomized 402 patients aged ≥60 years with acute ischemic strokes without AF to either enhanced and prolonged monitoring (EPM; 3×10-day Holter-ECG-monitoring) or standard-of-care (≥24 hours ECG-monitoring). The endpoint of the current analysis was AF within 36 months analyzed by intention to treat. Long-term follow-up was performed for 36 months.
RESULTS
RESULTS
Two hundred and seventy-four patients (80%) participated in the extended follow-up (median duration of follow-up was 36 months [interquartile range, 12 to 36]). During the first 6 months, more AF was documented in the EPM arm compared to the control arm (13.5% vs. 5.1%; 95% confidence interval, 2.9% to 14.4%; P=0.004). During months 6 to 36, AF was less detected in the EPM intervention arm than in the control arm (2.0% vs. 7.3%; 95% confidence interval, 0.7% to 9.9%; P=0.028). Overall, the detection rate of AF within 36 months was numerically higher within the EPM group (15.0% vs. 11.1%, P=0.30). Numerically less patients in the EPM arm had recurrent ischemic strokes (5.5% vs. 9.1%, P=0.18), transient ischemic attacks (3.0% vs. 4.5%, P=0.44) or died (4.5% vs. 6.6%, P=0.37).
CONCLUSIONS
CONCLUSIONS
Enhanced and prolonged ECG monitoring increased AF detection during the first six months, but there was significantly more clinical AF during months 6 to 36 observed in the usual-care arm. This suggests that EPM leads to an earlier detection of clinically relevant AF.
Identifiants
pubmed: 34911255
pii: jos.2021.01207
doi: 10.5853/jos.2021.01207
pmc: PMC8829482
doi:
Types de publication
Journal Article
Langues
eng
Pagination
98-107Références
N Engl J Med. 2019 May 16;380(20):1906-1917
pubmed: 31091372
Lancet. 2016 Aug 20;388(10046):806-17
pubmed: 27560276
BMC Neurol. 2015 Aug 05;15:129
pubmed: 26242880
Am Heart J. 2014 Oct;168(4):438-445.e1
pubmed: 25262252
Eur Heart J. 2010 Oct;31(19):2369-429
pubmed: 20802247
Stroke. 2011 Dec;42(12):3643-5
pubmed: 21998056
Circ Arrhythm Electrophysiol. 2016 Jan;9(1):e003333
pubmed: 26763225
J Neurol. 2013 Aug;260(8):2042-5
pubmed: 23632947
Neurology. 2017 Oct 10;89(15):1545-1552
pubmed: 28904084
Eur Heart J. 2017 May 1;38(17):1339-1344
pubmed: 28329139
Clin Res Cardiol. 2018 Oct;107(10):871-880
pubmed: 29704214
PLoS One. 2012;7(4):e34351
pubmed: 22509292
JAMA Cardiol. 2017 Oct 1;2(10):1120-1127
pubmed: 28842973
Stroke. 2020 Feb;51(2):395-401
pubmed: 31813354
Stroke. 2001 Dec 1;32(12):2735-40
pubmed: 11739965
N Engl J Med. 2014 Jun 26;370(26):2478-86
pubmed: 24963567
N Engl J Med. 2014 Jun 26;370(26):2467-77
pubmed: 24963566
PLoS One. 2013 Jun 28;8(6):e67602
pubmed: 23840747
N Engl J Med. 2018 Jun 07;378(23):2191-2201
pubmed: 29766772
Stroke. 2019 Aug;50(8):2175-2180
pubmed: 31216964
Lancet Neurol. 2017 Apr;16(4):282-290
pubmed: 28187920
Int J Stroke. 2015 Jun;10(4):534-40
pubmed: 23489996